Incyte: Q3 Earnings Ramping Up Growth To Jump The Patent Cliff

Thank you for reading my research on Seeking Alpha. If you want to learn even more about my method and how I discover these investment opportunities, please check out my subscription marketplace service, Compounding Healthcare , and sign up for a free trial.It has been nearly two years since my previous Incyte Corporation (NASDAQ: INCY ) article, where I discussed the potential for the company to maintain their growth trajectory despite the threat of Jakafi's impending patent expiration. Looking back, it lo ...